Logo Logo
Hilfe
Hilfe
Switch Language to English

Kogan, Daniel; Grabner, Alexander; Yanucil, Christopher; Faul, Christian und Ulaganathan, Vijay Kumar (2018): STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion. In: Journal of Clinical Investigation, Bd. 128, Nr. 5: S. 1867-1872

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Immune evasion and the suppression of antitumor responses during cancer progression are considered hallmarks of cancer and are typically attributed to tumor-derived factors. Although the molecular basis for the crosstalk between tumor and immune cells is an area of active investigation, whether host-specific germline variants can dictate immunosuppressive mechanisms has remained a challenge to address. A commonly occurring germline mutation (c.1162G>A/rs351855 G/A) in the FGFR4 (CD334) gene enhances signal transducer and activator of transcription 3 (STAT3) signaling and is associated with poor prognosis and accelerated progression of multiple cancer types. Here, using rs351855 SNP-knockin transgenic mice and Fgfr4-knockout mice, we reveal the genotype-specific gain of immunological function of suppressing the CD8/CD4(+)FOXP3(+)CD25(+) regulatory T cell ratio in vivo. Furthermore, using knockin transgenic mouse models for lung and breast cancers, we establish the host-specific, tumor-extrinsic functions of STAT3-enhancing germline variants in impeding the tumor infiltration of CD8 T cells. Thus, STAT3-enhancing germline receptor variants contribute to immune evasion through their pleiotropic functions in immune cells.

Dokument bearbeiten Dokument bearbeiten